332 related articles for article (PubMed ID: 2418059)
61. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
[TBL] [Abstract][Full Text] [Related]
62. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.
Emeis JJ; van Hinsbergh VW; Verheijen JH; Wijngaards G
Biochem Biophys Res Commun; 1983 Jan; 110(2):392-8. PubMed ID: 6404257
[TBL] [Abstract][Full Text] [Related]
63. Binding of tissue plasminogen activator to cultured human endothelial cells.
Hajjar KA; Hamel NM; Harpel PC; Nachman RL
J Clin Invest; 1987 Dec; 80(6):1712-9. PubMed ID: 3119664
[TBL] [Abstract][Full Text] [Related]
64. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
Levin EG; Loskutoff DJ
J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
[TBL] [Abstract][Full Text] [Related]
65. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture.
Casslén B; Andersson A; Nilsson IM; Astedt B
Proc Soc Exp Biol Med; 1986 Sep; 182(4):419-24. PubMed ID: 3090554
[TBL] [Abstract][Full Text] [Related]
66. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells.
Thompson EA; Nelles L; Collen D
Eur J Biochem; 1991 Nov; 201(3):627-32. PubMed ID: 1935958
[TBL] [Abstract][Full Text] [Related]
67. Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.
Levin EG
Blood; 1986 May; 67(5):1309-13. PubMed ID: 3083890
[TBL] [Abstract][Full Text] [Related]
68. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
69. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
70. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
Eaton DL; Baker JB
J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
[TBL] [Abstract][Full Text] [Related]
71. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins.
Speiser W; Anders E; Preissner KT; Wagner O; Müller-Berghaus G
Blood; 1987 Mar; 69(3):964-7. PubMed ID: 3101768
[TBL] [Abstract][Full Text] [Related]
72. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
van Mourik JA; Lawrence DA; Loskutoff DJ
J Biol Chem; 1984 Dec; 259(23):14914-21. PubMed ID: 6438106
[TBL] [Abstract][Full Text] [Related]
73. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture.
Shatos MA; Doherty JM; Stump DC; Thompson EA; Collen D
J Biol Chem; 1990 Nov; 265(33):20443-8. PubMed ID: 2122975
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP.
Francis RB; Neely S
Biochim Biophys Acta; 1989 Jul; 1012(2):207-13. PubMed ID: 2545266
[TBL] [Abstract][Full Text] [Related]
75. Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells.
Kimura Y; Yokoi K; Matsushita N; Okuda H
J Pharm Pharmacol; 1997 Aug; 49(8):816-22. PubMed ID: 9379363
[TBL] [Abstract][Full Text] [Related]
76. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
[TBL] [Abstract][Full Text] [Related]
77. Habutobin releases plasminogen activator (U-PA) from bovine pulmonary artery endothelial cells.
Sunagawa M; Hanashiro K; Nakamura M; Kosugi T
Toxicon; 1996 Jun; 34(6):691-9. PubMed ID: 8817813
[TBL] [Abstract][Full Text] [Related]
78. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
Erickson LA; Ginsberg MH; Loskutoff DJ
J Clin Invest; 1984 Oct; 74(4):1465-72. PubMed ID: 6434594
[TBL] [Abstract][Full Text] [Related]
79. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.
Booyse FM; Scheinbuks J; Lin PH; Traylor M; Bruce R
J Biol Chem; 1988 Oct; 263(29):15129-38. PubMed ID: 3139666
[TBL] [Abstract][Full Text] [Related]
80. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels.
van Hinsbergh VW; Binnema D; Scheffer MA; Sprengers ED; Kooistra T; Rijken DC
Arteriosclerosis; 1987; 7(4):389-400. PubMed ID: 3300618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]